Director, Supply Chain and CMO Outsourcing, Procurement jobs in United States
cer-icon
Apply on Employer Site
company-logo

Sarepta Therapeutics · 23 hours ago

Director, Supply Chain and CMO Outsourcing, Procurement

Sarepta Therapeutics is a leader in genetic medicine focused on Duchenne muscular dystrophy and is seeking a Director of Supply Chain and CMO Procurement. This role involves building and executing strategic sourcing strategies, managing supplier relationships, and collaborating with various business partners to support the company's manufacturing and supply chain objectives.

BiotechnologyGeneticsHealth CareTherapeutics
check
Growth Opportunities
badNo H1Bnote

Responsibilities

Collaborates and builds productive relationships with Supply Chain, Quality, Process Development and Manufacturing business partners and stakeholders while developing relationships with external key suppliers/ CDMO/CMO to identify opportunities to gain efficiencies, drive cost savings, proactively respond to business needs, and reduce risk while fulfilling business requirements
Partnering with stakeholders to align prioritization and lead execution
Support the development category and sourcing strategies for siRNA program development and clinical material supply, and commercial lunch readiness. Identify potential CDMO/CMO for new programs and ensure right-size capacity for programs/products at different stages
Lead category strategy implementation as well as value creation initiatives in support of business priorities and deliver cost savings in Drug Substance, Drug Product, Pack & Label, and domestic and internal Distribution
Supports the business team with identification of all applicable risks as part of the Sourcing process, including coordination with the key business stakeholder to properly assess and develop mitigation plans, where necessary
Ensures accurate reporting of Procurement key performance measures (operational metrics, savings, quality, customer service, etc.) for the category and tracks ROI
Identify COGS savings opportunities and drive implementation
Leads supplier identification / selection and implement RFx activities
Lead negotiations of clinical and commercial supply agreements with key suppliers/CMOs/CMP Labs, and drive prioritization alignment across Business, Finance and Legal and external partners
Implementing RFx activities
Preparing and implementing advanced negotiation strategies. Manage complex negotiations on price and terms, partnering with stakeholders and Legal to negotiate and finalize agreements
Manages the Supplier/CMO Performance/Relationship Management process and ensures performance and accountability are tracked and improved
Maximizing values from our supplier relationships
Develop and maintain strong vendor relationships to ensure continuity of supply and innovation in processes

Qualification

Sourcing & ProcurementGMP TestingCategory ManagementContract NegotiationSupplier Relationship ManagementFinancial AnalysisMicrosoft OfficeBusiness AcumenCommunication SkillsNegotiation Skills

Required

10+ years of demonstrated relevant Sourcing & Procurement experience in QC GMP Testing/Supply Chain/CMC sourcing and experience in RNA and siRNA manufacturing or chemistry CMO outsourcing is preferred
Demonstrated understanding of GMP requirements and international supply chain complexity
Experience working with stakeholders/partners at all levels, across the organization
In-depth strategic and operational procurement experience with knowledge of category management
Outstanding communication
Strong negotiation skills
Strong business acumen and financial analysis capabilities; ability to develop solid business cases to demonstrate the value proposition to move forward with project investment
Advanced skills with Microsoft Office Applications; Word, Excel, Powerpoint, and Outlook

Benefits

Physical and Emotional Wellness
Financial Wellness
Support for Caregivers
Competitive compensation and benefit package

Company

Sarepta Therapeutics

company-logo
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.

Funding

Current Stage
Public Company
Total Funding
$2.88B
Key Investors
Michael Andrew ChambersPharmakon AdvisorsMidCap Financial
2025-12-11Post Ipo Debt· $291.4M
2025-08-21Post Ipo Equity
2025-08-21Post Ipo Debt· $602M

Leadership Team

leader-logo
Ian Estepan
Executive Vice President, Chief Financial Officer
linkedin
K
Kathy Behrens Wilsey
Director
linkedin
Company data provided by crunchbase